{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T04:44:58Z","timestamp":1792903498183,"version":"4.5.0"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T00:00:00Z","timestamp":1629504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T00:00:00Z","timestamp":1629504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"DOI":"10.1007\/s12016-021-08885-y","type":"journal-article","created":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T13:02:41Z","timestamp":1629550961000},"page":"36-54","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Defects of the Innate Immune System and Related Immune Deficiencies"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3884-081X","authenticated-orcid":false,"given":"Nicole","family":"Akar-Ghibril","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,21]]},"reference":[{"key":"8885_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fped.2017.00083","volume":"5","author":"K Gobin","year":"2017","unstructured":"Gobin K et al (2017) IRAK4 deficiency in a patient with recurrent pneumococcal infections: case report and review of the literature. Front Pediatr 5:83","journal-title":"Front Pediatr"},{"issue":"5","key":"8885_CR2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s11882-011-0212-9","volume":"11","author":"SD Rosenzweig","year":"2011","unstructured":"Rosenzweig SD, Holland SM (2011) Recent insights into the pathobiology of innate immune deficiencies. Curr Allergy Asthma Rep 11(5):369\u2013377","journal-title":"Curr Allergy Asthma Rep"},{"issue":"5963","key":"8885_CR3","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1126\/science.1183021","volume":"327","author":"A Iwasaki","year":"2010","unstructured":"Iwasaki A, Medzhitov R (2010) Regulation of adaptive immunity by the innate immune system. Science 327(5963):291\u2013295","journal-title":"Science"},{"issue":"2 Suppl 2","key":"8885_CR4","doi-asserted-by":"publisher","first-page":"S182","DOI":"10.1016\/j.jaci.2009.07.053","volume":"125","author":"LD Notarangelo","year":"2010","unstructured":"Notarangelo LD (2010) Primary immunodeficiencies. J Allergy Clin Immunol 125(2 Suppl 2):S182\u2013S194","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"8885_CR5","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1128\/CMR.00001-11","volume":"24","author":"C Picard","year":"2011","unstructured":"Picard C, Casanova JL, Puel A (2011) Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IkappaBalpha deficiency. Clin Microbiol Rev 24(3):490\u2013497","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"8885_CR6","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s10875-014-0003-x","volume":"34","author":"J Routes","year":"2014","unstructured":"Routes J et al (2014) ICON: the early diagnosis of congenital immunodeficiencies. J Clin Immunol 34(4):398\u2013424","journal-title":"J Clin Immunol"},{"key":"8885_CR7","doi-asserted-by":"crossref","unstructured":"Al-Muhsen S, Casanova JL (2008) The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases. J Allergy Clin Immunol 122(6):1043\u20131051; quiz 1052\u20133","DOI":"10.1016\/j.jaci.2008.10.037"},{"key":"8885_CR8","doi-asserted-by":"crossref","unstructured":"Smahi A et al (2000) Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature 405(6785):466\u2013472","DOI":"10.1038\/35013114"},{"issue":"7","key":"8885_CR9","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1172\/JCI18714","volume":"112","author":"G Courtois","year":"2003","unstructured":"Courtois G et al (2003) A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. J Clin Invest 112(7):1108\u20131115","journal-title":"J Clin Invest"},{"issue":"6","key":"8885_CR10","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/humu.20740","volume":"29","author":"E Lopez-Granados","year":"2008","unstructured":"Lopez-Granados E et al (2008) A novel mutation in NFKBIA\/IKBA results in a degradation-resistant N-truncated protein and is associated with ectodermal dysplasia with immunodeficiency. Hum Mutat 29(6):861\u2013868","journal-title":"Hum Mutat"},{"issue":"4","key":"8885_CR11","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.jaci.2004.01.762","volume":"113","author":"JS Orange","year":"2004","unstructured":"Orange JS et al (2004) The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation. J Allergy Clin Immunol 113(4):725\u2013733","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"8885_CR12","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10875-019-00728-y","volume":"40","author":"S Heller","year":"2020","unstructured":"Heller S et al (2020) T cell impairment is predictive for a severe clinical course in NEMO deficiency. J Clin Immunol 40(3):421\u2013434","journal-title":"J Clin Immunol"},{"key":"8885_CR13","doi-asserted-by":"crossref","unstructured":"Hanson EP et al (2008) Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity. J Allergy Clin Immunol 122(6):1169\u20131177 e16","DOI":"10.1016\/j.jaci.2008.08.018"},{"issue":"1","key":"8885_CR14","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.clim.2009.03.514","volume":"132","author":"LE Cheng","year":"2009","unstructured":"Cheng LE et al (2009) Persistent systemic inflammation and atypical enterocolitis in patients with NEMO syndrome. Clin Immunol 132(1):124\u2013131","journal-title":"Clin Immunol"},{"issue":"5 Suppl 1","key":"8885_CR15","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S1081-1206(10)61142-8","volume":"94","author":"FA Bonilla","year":"2005","unstructured":"Bonilla FA et al (2005) Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol 94(5 Suppl 1):S1-63","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"12","key":"8885_CR16","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1182\/blood-2017-03-771600","volume":"130","author":"C Miot","year":"2017","unstructured":"Miot C et al (2017) Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG\/NEMO mutations. Blood 130(12):1456\u20131467","journal-title":"Blood"},{"issue":"6","key":"8885_CR17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/MD.0b013e3181fd8ec3","volume":"89","author":"C Picard","year":"2010","unstructured":"Picard C et al (2010) Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency. Medicine (Baltimore) 89(6):403\u2013425","journal-title":"Medicine (Baltimore)"},{"key":"8885_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.clim.2019.07.004","volume":"207","author":"CD Platt","year":"2019","unstructured":"Platt CD et al (2019) A novel truncating mutation in MYD88 in a patient with BCG adenitis, neutropenia and delayed umbilical cord separation. Clin Immunol 207:40\u201342","journal-title":"Clin Immunol"},{"key":"8885_CR19","doi-asserted-by":"crossref","unstructured":"Israel L et al (2017) Human adaptive immunity rescues an inborn error of innate immunity. Cell 168(5):789\u2013800 e10","DOI":"10.1016\/j.cell.2017.01.039"},{"issue":"9","key":"8885_CR20","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1084\/jem.20111316","volume":"209","author":"M Herman","year":"2012","unstructured":"Herman M et al (2012) Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood. J Exp Med 209(9):1567\u20131582","journal-title":"J Exp Med"},{"issue":"5844","key":"8885_CR21","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1126\/science.1139522","volume":"317","author":"SY Zhang","year":"2007","unstructured":"Zhang SY et al (2007) TLR3 deficiency in patients with herpes simplex encephalitis. Science 317(5844):1522\u20131527","journal-title":"Science"},{"issue":"10","key":"8885_CR22","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1084\/jem.20101568","volume":"208","author":"Y Guo","year":"2011","unstructured":"Guo Y et al (2011) Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity. J Exp Med 208(10):2083\u20132098","journal-title":"J Exp Med"},{"issue":"30","key":"8885_CR23","doi-asserted-by":"publisher","first-page":"23208","DOI":"10.1074\/jbc.M109.047464","volume":"285","author":"C Gorbea","year":"2010","unstructured":"Gorbea C et al (2010) A role for Toll-like receptor 3 variants in host susceptibility to enteroviral myocarditis and dilated cardiomyopathy. J Biol Chem 285(30):23208\u201323223","journal-title":"J Biol Chem"},{"issue":"5797","key":"8885_CR24","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1126\/science.1128346","volume":"314","author":"A Casrouge","year":"2006","unstructured":"Casrouge A et al (2006) Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314(5797):308\u2013312","journal-title":"Science"},{"key":"8885_CR25","doi-asserted-by":"crossref","unstructured":"Perez de Diego R et al (2010) Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity 33(3):400\u2013411","DOI":"10.1016\/j.immuni.2010.08.014"},{"issue":"12","key":"8885_CR26","doi-asserted-by":"publisher","first-page":"4889","DOI":"10.1172\/JCI59259","volume":"121","author":"V Sancho-Shimizu","year":"2011","unstructured":"Sancho-Shimizu V et al (2011) Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency. J Clin Invest 121(12):4889\u20134902","journal-title":"J Clin Invest"},{"issue":"9","key":"8885_CR27","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1084\/jem.20142274","volume":"212","author":"LL Andersen","year":"2015","unstructured":"Andersen LL et al (2015) Functional IRF3 deficiency in a patient with herpes simplex encephalitis. J Exp Med 212(9):1371\u20131379","journal-title":"J Exp Med"},{"issue":"8","key":"8885_CR28","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1073\/pnas.1220098110","volume":"110","author":"S Hambleton","year":"2013","unstructured":"Hambleton S et al (2013) STAT2 deficiency and susceptibility to viral illness in humans. Proc Natl Acad Sci USA 110(8):3053\u20133058","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"8885_CR29","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s10875-017-0464-9","volume":"38","author":"C Picard","year":"2018","unstructured":"Picard C et al (2018) International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity. J Clin Immunol 38(1):96\u2013128","journal-title":"J Clin Immunol"},{"issue":"1","key":"8885_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/cei.12160","volume":"175","author":"MA Lee-Kirsch","year":"2014","unstructured":"Lee-Kirsch MA, Wolf C, Gunther C (2014) Aicardi-Goutieres syndrome: a model disease for systemic autoimmunity. Clin Exp Immunol 175(1):17\u201324","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"8885_CR31","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/art.40805","volume":"71","author":"K Meesilpavikkai","year":"2019","unstructured":"Meesilpavikkai K et al (2019) Efficacy of baricitinib in the treatment of chilblains associated with Aicardi-Goutieres syndrome, a type I interferonopathy. Arthritis Rheumatol 71(5):829\u2013831","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"8885_CR32","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.autrev.2012.08.012","volume":"12","author":"E Fazzi","year":"2013","unstructured":"Fazzi E et al (2013) Aicardi-Goutieres syndrome, a rare neurological disease in children: a new autoimmune disorder? Autoimmun Rev 12(4):506\u2013509","journal-title":"Autoimmun Rev"},{"issue":"3","key":"8885_CR33","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s10875-016-0252-y","volume":"36","author":"TA Briggs","year":"2016","unstructured":"Briggs TA et al (2016) Spondyloenchondrodysplasia due to mutations in ACP5: a comprehensive survey. J Clin Immunol 36(3):220\u2013234","journal-title":"J Clin Immunol"},{"issue":"6","key":"8885_CR34","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1007\/s10875-020-00813-7","volume":"40","author":"SA Mahdaviani","year":"2020","unstructured":"Mahdaviani SA et al (2020) Mendelian susceptibility to mycobacterial disease (MSMD): clinical and genetic features of 32 Iranian patients. J Clin Immunol 40(6):872\u2013882","journal-title":"J Clin Immunol"},{"issue":"6\u20137","key":"8885_CR35","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00439-020-02120-y","volume":"139","author":"J Bustamante","year":"2020","unstructured":"Bustamante J (2020) Mendelian susceptibility to mycobacterial disease: recent discoveries. Hum Genet 139(6\u20137):993\u20131000","journal-title":"Hum Genet"},{"issue":"5","key":"8885_CR36","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.imbio.2012.08.281","volume":"218","author":"WI Lee","year":"2013","unstructured":"Lee WI et al (2013) Patients with inhibitory and neutralizing auto-antibodies to interferon-gamma resemble the sporadic adult-onset phenotype of Mendelian Susceptibility to Mycobacterial Disease (MSMD) lacking Bacille Calmette-Guerin (BCG)-induced diseases. Immunobiology 218(5):762\u2013771","journal-title":"Immunobiology"},{"issue":"6","key":"8885_CR37","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/MD.0b013e3181fdd832","volume":"89","author":"L de Beaucoudrey","year":"2010","unstructured":"de Beaucoudrey L et al (2010) Revisiting human IL-12Rbeta1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore) 89(6):381\u2013402","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"8885_CR38","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1172\/JCI37083","volume":"119","author":"A Chapgier","year":"2009","unstructured":"Chapgier A et al (2009) A partial form of recessive STAT1 deficiency in humans. J Clin Invest 119(6):1502\u20131514","journal-title":"J Clin Invest"},{"issue":"3","key":"8885_CR39","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/ng1097","volume":"33","author":"S Dupuis","year":"2003","unstructured":"Dupuis S et al (2003) Impaired response to interferon-alpha\/beta and lethal viral disease in human STAT1 deficiency. Nat Genet 33(3):388\u2013391","journal-title":"Nat Genet"},{"issue":"6102","key":"8885_CR40","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1126\/science.1224026","volume":"337","author":"D Bogunovic","year":"2012","unstructured":"Bogunovic D et al (2012) Mycobacterial disease and impaired IFN-gamma immunity in humans with inherited ISG15 deficiency. Science 337(6102):1684\u20131688","journal-title":"Science"},{"issue":"6","key":"8885_CR41","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.jpeds.2004.08.021","volume":"145","author":"J Roesler","year":"2004","unstructured":"Roesler J et al (2004) Hematopoietic stem cell transplantation for complete IFN-gamma receptor 1 deficiency: a multi-institutional survey. J Pediatr 145(6):806\u2013812","journal-title":"J Pediatr"},{"issue":"25","key":"8885_CR42","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","volume":"127","author":"J Toubiana","year":"2016","unstructured":"Toubiana J et al (2016) Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. Blood 127(25):3154\u20133164","journal-title":"Blood"},{"key":"8885_CR43","doi-asserted-by":"crossref","unstructured":"Engelhardt KR, Grimbacher B (2012) Mendelian traits causing susceptibility to mucocutaneous fungal infections in human subjects. J Allergy Clin Immunol 129(2):294\u2013305; quiz 306\u20137","DOI":"10.1016\/j.jaci.2011.12.966"},{"issue":"18","key":"8885_CR44","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1056\/NEJMoa0810719","volume":"361","author":"EO Glocker","year":"2009","unstructured":"Glocker EO et al (2009) A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med 361(18):1727\u20131735","journal-title":"N Engl J Med"},{"issue":"13","key":"8885_CR45","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1182\/blood-2012-08-450551","volume":"121","author":"A Drewniak","year":"2013","unstructured":"Drewniak A et al (2013) Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency. Blood 121(13):2385\u20132392","journal-title":"Blood"},{"issue":"5","key":"8885_CR46","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s10875-019-00662-z","volume":"39","author":"F Queiroz-Telles","year":"2019","unstructured":"Queiroz-Telles F et al (2019) Successful allogenic stem cell transplantation in patients with inherited CARD9 deficiency. J Clin Immunol 39(5):462\u2013469","journal-title":"J Clin Immunol"},{"issue":"5","key":"8885_CR47","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s10875-016-0283-4","volume":"36","author":"AK de Medeiros","year":"2016","unstructured":"de Medeiros AK et al (2016) Erratum to: Chronic and invasive fungal infections in a family with CARD9 deficiency. J Clin Immunol 36(5):528","journal-title":"J Clin Immunol"},{"issue":"18","key":"8885_CR48","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1056\/NEJMoa0901053","volume":"361","author":"B Ferwerda","year":"2009","unstructured":"Ferwerda B et al (2009) Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 361(18):1760\u20131767","journal-title":"N Engl J Med"},{"key":"8885_CR49","doi-asserted-by":"crossref","unstructured":"Shamriz O et al (2020) Chronic mucocutaneous candidiasis in early life: insights into immune mechanisms and novel targeted therapies. Front Immunol 11:593289","DOI":"10.3389\/fimmu.2020.593289"},{"issue":"1","key":"8885_CR50","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/cid\/ciu215","volume":"59","author":"C Gavino","year":"2014","unstructured":"Gavino C et al (2014) CARD9 deficiency and spontaneous central nervous system candidiasis: complete clinical remission with GM-CSF therapy. Clin Infect Dis 59(1):81\u201384","journal-title":"Clin Infect Dis"},{"issue":"6","key":"8885_CR51","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.smim.2006.07.008","volume":"18","author":"G Orth","year":"2006","unstructured":"Orth G (2006) Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses. Semin Immunol 18(6):362\u2013374","journal-title":"Semin Immunol"},{"issue":"1","key":"8885_CR52","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s10875-012-9749-1","volume":"33","author":"A Crequer","year":"2013","unstructured":"Crequer A et al (2013) EVER2 deficiency is associated with mild T-cell abnormalities. J Clin Immunol 33(1):14\u201321","journal-title":"J Clin Immunol"},{"issue":"3","key":"8885_CR53","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jdermsci.2007.01.002","volume":"46","author":"B Akgul","year":"2007","unstructured":"Akgul B et al (2007) A distinct variant of Epidermodysplasia verruciformis in a Turkish family lacking EVER1 and EVER2 mutations. J Dermatol Sci 46(3):214\u2013216","journal-title":"J Dermatol Sci"},{"key":"8885_CR54","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.3389\/fmicb.2018.01222","volume":"9","author":"SJ de Jong","year":"2018","unstructured":"de Jong SJ et al (2018) Epidermodysplasia verruciformis: inborn errors of immunity to human beta-papillomaviruses. Front Microbiol 9:1222","journal-title":"Front Microbiol"},{"issue":"4","key":"8885_CR55","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/ng1044","volume":"32","author":"N Ramoz","year":"2002","unstructured":"Ramoz N et al (2002) Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 32(4):579\u2013581","journal-title":"Nat Genet"},{"key":"8885_CR56","doi-asserted-by":"crossref","unstructured":"Lazarczyk M et al (2012) EVER proteins, key elements of the natural anti-human papillomavirus barrier, are regulated upon T-cell activation. PLoS One 7(6):e39995","DOI":"10.1371\/journal.pone.0039995"},{"key":"8885_CR57","doi-asserted-by":"crossref","unstructured":"Crequer A et al (2012) Inherited MST1 deficiency underlies susceptibility to EV-HPV infections. PLoS One 7(8):e44010","DOI":"10.1371\/journal.pone.0044010"},{"issue":"9","key":"8885_CR58","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1084\/jem.20170308","volume":"215","author":"SJ de Jong","year":"2018","unstructured":"de Jong SJ et al (2018) The human CIB1-EVER1-EVER2 complex governs keratinocyte-intrinsic immunity to beta-papillomaviruses. J Exp Med 215(9):2289\u20132310","journal-title":"J Exp Med"},{"issue":"15","key":"8885_CR59","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1182\/blood-2011-09-378364","volume":"119","author":"NT Nehme","year":"2012","unstructured":"Nehme NT et al (2012) MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T-cell survival. Blood 119(15):3458\u20133468","journal-title":"Blood"},{"key":"8885_CR60","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.clim.2017.08.007","volume":"183","author":"CD Platt","year":"2017","unstructured":"Platt CD et al (2017) Combined immunodeficiency with EBV positive B cell lymphoma and epidermodysplasia verruciformis due to a novel homozygous mutation in RASGRP1. Clin Immunol 183:142\u2013144","journal-title":"Clin Immunol"},{"issue":"11","key":"8885_CR61","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1093\/cid\/ciy942","volume":"68","author":"L Youssefian","year":"2019","unstructured":"Youssefian L et al (2019) Inherited Interleukin 2-Inducible T-Cell (ITK) Kinase deficiency in siblings with Epidermodysplasia Verruciformis and Hodgkin Lymphoma. Clin Infect Dis 68(11):1938\u20131941","journal-title":"Clin Infect Dis"},{"issue":"1","key":"8885_CR62","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/01.moh.0000149609.37309.0a","volume":"12","author":"T Lawrence","year":"2005","unstructured":"Lawrence T et al (2005) Autosomal-dominant primary immunodeficiencies. Curr Opin Hematol 12(1):22\u201330","journal-title":"Curr Opin Hematol"},{"issue":"6135","key":"8885_CR63","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1126\/science.1234864","volume":"340","author":"A Bolze","year":"2013","unstructured":"Bolze A et al (2013) Ribosomal protein SA haploinsufficiency in humans with isolated congenital asplenia. Science 340(6135):976\u2013978","journal-title":"Science"},{"issue":"20","key":"8885_CR64","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1182\/blood-2018-11-844563","volume":"133","author":"MC Dinauer","year":"2019","unstructured":"Dinauer MC (2019) Inflammatory consequences of inherited disorders affecting neutrophil function. Blood 133(20):2130\u20132139","journal-title":"Blood"},{"issue":"1","key":"8885_CR65","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1056\/NEJMoa0805051","volume":"360","author":"K Boztug","year":"2009","unstructured":"Boztug K et al (2009) A syndrome with congenital neutropenia and mutations in G6PC3. N Engl J Med 360(1):32\u201343","journal-title":"N Engl J Med"},{"key":"8885_CR66","doi-asserted-by":"publisher","first-page":"17032","DOI":"10.1038\/nrdp.2017.32","volume":"3","author":"J Skokowa","year":"2017","unstructured":"Skokowa J et al (2017) Severe congenital neutropenias. Nat Rev Dis Primers 3:17032","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"8885_CR67","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12881-020-0971-z","volume":"21","author":"P Venugopal","year":"2020","unstructured":"Venugopal P et al (2020) Two monogenic disorders masquerading as one: severe congenital neutropenia with monocytosis and non-syndromic sensorineural hearing loss. BMC Med Genet 21(1):35","journal-title":"BMC Med Genet"},{"issue":"3","key":"8885_CR68","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ng1170","volume":"34","author":"RE Person","year":"2003","unstructured":"Person RE et al (2003) Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat Genet 34(3):308\u2013312","journal-title":"Nat Genet"},{"key":"8885_CR69","doi-asserted-by":"crossref","unstructured":"Lyu B, Lyu W, Zhang X (2020) Kostmann syndrome with neurological abnormalities: a case report and literature review. Front Pediatr 8:586859","DOI":"10.3389\/fped.2020.586859"},{"key":"8885_CR70","doi-asserted-by":"crossref","unstructured":"Shah RK et al (2017) A novel homozygous VPS45 p.P468L mutation leading to severe congenital neutropenia with myelofibrosis. Pediatr Blood Cancer 64(9)","DOI":"10.1002\/pbc.26571"},{"issue":"12","key":"8885_CR71","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1182\/blood-2017-12-820308","volume":"132","author":"C Bellanne-Chantelot","year":"2018","unstructured":"Bellanne-Chantelot C et al (2018) Mutations in the SRP54 gene cause severe congenital neutropenia as well as Shwachman-Diamond-like syndrome. Blood 132(12):1318\u20131331","journal-title":"Blood"},{"issue":"1","key":"8885_CR72","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/bjh.17137","volume":"192","author":"A Khandagale","year":"2021","unstructured":"Khandagale A et al (2021) Severe congenital neutropenia-associated JAGN1 mutations unleash a calpain-dependent cell death programme in myeloid cells. Br J Haematol 192(1):200\u2013211","journal-title":"Br J Haematol"},{"issue":"8","key":"8885_CR73","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1056\/NEJM199508243330804","volume":"333","author":"F Dong","year":"1995","unstructured":"Dong F et al (1995) Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N Engl J Med 333(8):487\u2013493","journal-title":"N Engl J Med"},{"issue":"7","key":"8885_CR74","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/humu.22563","volume":"35","author":"V Makaryan","year":"2014","unstructured":"Makaryan V et al (2014) TCIRG1-associated congenital neutropenia. Hum Mutat 35(7):824\u2013827","journal-title":"Hum Mutat"},{"issue":"10","key":"8885_CR75","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1182\/blood.V81.10.2496.2496","volume":"81","author":"DC Dale","year":"1993","unstructured":"Dale DC et al (1993) A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood 81(10):2496\u20132502","journal-title":"Blood"},{"key":"8885_CR76","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3389\/fimmu.2019.00254","volume":"10","author":"SC Fagerholm","year":"2019","unstructured":"Fagerholm SC et al (2019) Beta2-Integrins and interacting proteins in Leukocyte trafficking, immune suppression, and immunodeficiency disease. Front Immunol 10:254","journal-title":"Front Immunol"},{"issue":"12","key":"8885_CR77","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1056\/NEJMoa1612197","volume":"376","author":"NM Moutsopoulos","year":"2017","unstructured":"Moutsopoulos NM et al (2017) Interleukin-12 and Interleukin-23 Blockade in Leukocyte Adhesion Deficiency Type 1. N Engl J Med 376(12):1141\u20131146","journal-title":"N Engl J Med"},{"key":"8885_CR78","doi-asserted-by":"crossref","unstructured":"Wolach B et al (2019) Leucocyte adhesion deficiency-A multicentre national experience. Eur J Clin Invest 49(2):e13047","DOI":"10.1111\/eci.13047"},{"issue":"2","key":"8885_CR79","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s10875-009-9354-0","volume":"30","author":"Y Gazit","year":"2010","unstructured":"Gazit Y et al (2010) Leukocyte adhesion deficiency type II: long-term follow-up and review of the literature. J Clin Immunol 30(2):308\u2013313","journal-title":"J Clin Immunol"},{"issue":"1","key":"8885_CR80","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s12016-009-8132-3","volume":"38","author":"A Etzioni","year":"2010","unstructured":"Etzioni A (2010) Defects in the leukocyte adhesion cascade. Clin Rev Allergy Immunol 38(1):54\u201360","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"8885_CR81","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nm.1931","volume":"15","author":"L Svensson","year":"2009","unstructured":"Svensson L et al (2009) Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation. Nat Med 15(3):306\u2013312","journal-title":"Nat Med"},{"key":"8885_CR82","doi-asserted-by":"crossref","unstructured":"Essa MF et al (2020) Successful hematopoietic stem cell transplant in leukocyte adhesion deficiency type III presenting primarily as malignant infantile osteopetrosis. Clin Immunol 213:108365","DOI":"10.1016\/j.clim.2020.108365"},{"issue":"6","key":"8885_CR83","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s10875-019-00665-w","volume":"39","author":"LE Heusinkveld","year":"2019","unstructured":"Heusinkveld LE et al (2019) WHIM Syndrome: from Pathogenesis Towards Personalized Medicine and Cure. J Clin Immunol 39(6):532\u2013556","journal-title":"J Clin Immunol"},{"issue":"4","key":"8885_CR84","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.jpeds.2012.05.058","volume":"161","author":"R Badolato","year":"2012","unstructured":"Badolato R et al (2012) Tetralogy of fallot is an uncommon manifestation of warts, hypogammaglobulinemia, infections, and myelokathexis syndrome. J Pediatr 161(4):763\u2013765","journal-title":"J Pediatr"},{"issue":"18","key":"8885_CR85","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1182\/blood-2011-07-368084","volume":"118","author":"DH McDermott","year":"2011","unstructured":"McDermott DH et al (2011) The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome. Blood 118(18):4957\u20134962","journal-title":"Blood"},{"issue":"2","key":"8885_CR86","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1056\/NEJMoa1808575","volume":"380","author":"DH McDermott","year":"2019","unstructured":"McDermott DH et al (2019) Plerixafor for the treatment of WHIM syndrome. N Engl J Med 380(2):163\u2013170","journal-title":"N Engl J Med"},{"issue":"26","key":"8885_CR87","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1182\/blood.2020007197","volume":"136","author":"DC Dale","year":"2020","unstructured":"Dale DC et al (2020) Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndrome. Blood 136(26):2994\u20133003","journal-title":"Blood"},{"issue":"3","key":"8885_CR88","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1600-0609.2009.01368.x","volume":"84","author":"G Krivan","year":"2010","unstructured":"Krivan G et al (2010) Successful umbilical cord blood stem cell transplantation in a child with WHIM syndrome. Eur J Haematol 84(3):274\u2013275","journal-title":"Eur J Haematol"},{"key":"8885_CR89","doi-asserted-by":"crossref","unstructured":"Moens L et al (2016) Successful hematopoietic stem cell transplantation for myelofibrosis in an adult with warts-hypogammaglobulinemia-immunodeficiency-myelokathexis syndrome. J Allergy Clin Immunol 138(5):1485\u20131489 e2","DOI":"10.1016\/j.jaci.2016.04.057"},{"key":"8885_CR90","doi-asserted-by":"crossref","unstructured":"Yu HH, Yang YH, Chiang BL (2020) Chronic granulomatous disease: a comprehensive review. Clin Rev Allergy Immunol","DOI":"10.1007\/s12016-020-08800-x"},{"issue":"2","key":"8885_CR91","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/bjh.16939","volume":"192","author":"AR Gennery","year":"2021","unstructured":"Gennery AR (2021) Progress in treating chronic granulomatous disease. Br J Haematol 192(2):251\u2013264","journal-title":"Br J Haematol"},{"issue":"8","key":"8885_CR92","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1093\/cid\/ciu1154","volume":"60","author":"BE Marciano","year":"2015","unstructured":"Marciano BE et al (2015) Common severe infections in chronic granulomatous disease. Clin Infect Dis 60(8):1176\u20131183","journal-title":"Clin Infect Dis"},{"issue":"9","key":"8885_CR93","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1172\/JCI97116","volume":"128","author":"A van de Geer","year":"2018","unstructured":"van de Geer A et al (2018) Inherited p40phox deficiency differs from classic chronic granulomatous disease. J Clin Invest 128(9):3957\u20133975","journal-title":"J Clin Invest"},{"issue":"9","key":"8885_CR94","doi-asserted-by":"publisher","first-page":"4654","DOI":"10.1073\/pnas.080074897","volume":"97","author":"DR Ambruso","year":"2000","unstructured":"Ambruso DR et al (2000) Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation. Proc Natl Acad Sci USA 97(9):4654\u20134659","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"8885_CR95","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.jaci.2017.04.035","volume":"141","author":"BE Marciano","year":"2018","unstructured":"Marciano BE et al (2018) X-linked carriers of chronic granulomatous disease: Illness, lyonization, and stability. J Allergy Clin Immunol 141(1):365\u2013371","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"8885_CR96","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s10875-020-00750-5","volume":"40","author":"L Blancas-Galicia","year":"2020","unstructured":"Blancas-Galicia L et al (2020) Genetic, immunological, and clinical features of the first Mexican cohort of patients with chronic granulomatous disease. J Clin Immunol 40(3):475\u2013493","journal-title":"J Clin Immunol"},{"issue":"6","key":"8885_CR97","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.jaip.2019.02.004","volume":"7","author":"MG Seidel","year":"2019","unstructured":"Seidel MG et al (2019) The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity. J Allergy Clin Immunol Pract 7(6):1763\u20131770","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"27","key":"8885_CR98","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1056\/NEJMoa1007097","volume":"363","author":"DB Kuhns","year":"2010","unstructured":"Kuhns DB et al (2010) Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med 363(27):2600\u20132610","journal-title":"N Engl J Med"},{"key":"8885_CR99","doi-asserted-by":"crossref","unstructured":"The International Chronic Granulomatous Disease Cooperative Study Group (1991) A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 324(8):509\u2013516","DOI":"10.1056\/NEJM199102213240801"},{"issue":"2","key":"8885_CR100","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.clim.2007.09.008","volume":"126","author":"B Martire","year":"2008","unstructured":"Martire B et al (2008) Clinical features, long-term follow-up and outcome of a large cohort of patients with chronic granulomatous disease: an Italian multicenter study. Clin Immunol 126(2):155\u2013164","journal-title":"Clin Immunol"},{"key":"8885_CR101","doi-asserted-by":"crossref","unstructured":"Dedieu C et al (2020) Outcome of chronic granulomatous disease - conventional treatment vs stem cell transplantation. Pediatr Allergy Immunol","DOI":"10.1111\/pai.13402"},{"issue":"10","key":"8885_CR102","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1182\/blood.2020005590","volume":"136","author":"R Chiesa","year":"2020","unstructured":"Chiesa R et al (2020) Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults. Blood 136(10):1201\u20131211","journal-title":"Blood"},{"issue":"2","key":"8885_CR103","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41591-019-0735-5","volume":"26","author":"DB Kohn","year":"2020","unstructured":"Kohn DB et al (2020) Lentiviral gene therapy for X-linked chronic granulomatous disease. Nat Med 26(2):200\u2013206","journal-title":"Nat Med"},{"issue":"3","key":"8885_CR104","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jaci.2013.07.020","volume":"132","author":"JS Orange","year":"2013","unstructured":"Orange JS (2013) Natural killer cell deficiency. J Allergy Clin Immunol 132(3):515\u2013525","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"8885_CR105","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11882-019-0836-8","volume":"19","author":"A Vargas-Hernandez","year":"2019","unstructured":"Vargas-Hernandez A, Forbes LR (2019) The impact of immunodeficiency on NK cell maturation and function. Curr Allergy Asthma Rep 19(1):2","journal-title":"Curr Allergy Asthma Rep"},{"issue":"6","key":"8885_CR106","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1182\/blood-2013-07-515528","volume":"123","author":"MA Spinner","year":"2014","unstructured":"Spinner MA et al (2014) GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood 123(6):809\u2013821","journal-title":"Blood"},{"issue":"5","key":"8885_CR107","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/bjh.16247","volume":"188","author":"DJ Bogaert","year":"2020","unstructured":"Bogaert DJ et al (2020) GATA2 deficiency and haematopoietic stem cell transplantation: challenges for the clinical practitioner. Br J Haematol 188(5):768\u2013773","journal-title":"Br J Haematol"},{"issue":"3","key":"8885_CR108","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1172\/JCI60224","volume":"122","author":"CR Hughes","year":"2012","unstructured":"Hughes CR et al (2012) MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans. J Clin Invest 122(3):814\u2013820","journal-title":"J Clin Invest"},{"issue":"3","key":"8885_CR109","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1172\/JCI61014","volume":"122","author":"L Gineau","year":"2012","unstructured":"Gineau L et al (2012) Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency. J Clin Invest 122(3):821\u2013832","journal-title":"J Clin Invest"},{"issue":"1","key":"8885_CR110","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1172\/JCI86276","volume":"127","author":"EM Mace","year":"2017","unstructured":"Mace EM et al (2017) Biallelic mutations in IRF8 impair human NK cell maturation and function. J Clin Invest 127(1):306\u2013320","journal-title":"J Clin Invest"},{"issue":"5","key":"8885_CR111","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1172\/JCI90727","volume":"127","author":"J Cottineau","year":"2017","unstructured":"Cottineau J et al (2017) Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency. J Clin Invest 127(5):1991\u20132006","journal-title":"J Clin Invest"},{"issue":"10","key":"8885_CR112","doi-asserted-by":"publisher","first-page":"3769","DOI":"10.1172\/JCI64837","volume":"122","author":"JT Grier","year":"2012","unstructured":"Grier JT et al (2012) Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity. J Clin Invest 122(10):3769\u20133780","journal-title":"J Clin Invest"},{"issue":"12","key":"8885_CR113","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1002\/eji.200939800","volume":"39","author":"J Diana","year":"2009","unstructured":"Diana J, Lehuen A (2009) NKT cells: friend or foe during viral infections? Eur J Immunol 39(12):3283\u20133291","journal-title":"Eur J Immunol"},{"issue":"2","key":"8885_CR114","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.molimm.2014.06.030","volume":"61","author":"AS Grumach","year":"2014","unstructured":"Grumach AS, Kirschfink M (2014) Are complement deficiencies really rare? Overview on prevalence, clinical importance and modern diagnostic approach. Mol Immunol 61(2):110\u2013117","journal-title":"Mol Immunol"},{"issue":"6","key":"8885_CR115","first-page":"982","volume":"10","author":"M Kirschfink","year":"2003","unstructured":"Kirschfink M, Mollnes TE (2003) Modern complement analysis. Clin Diagn Lab Immunol 10(6):982\u2013989","journal-title":"Clin Diagn Lab Immunol"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-021-08885-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-021-08885-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-021-08885-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T15:14:25Z","timestamp":1673450065000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-021-08885-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,21]]},"references-count":115,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["8885"],"URL":"https:\/\/doi.org\/10.1007\/s12016-021-08885-y","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,21]]},"assertion":[{"value":"30 July 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}